DigestRedComo funciona
Red
/
Empresas
La
No verificado

Laminar Pharmaceuticals, S.A.

Sobre qué escribimos

BiologíaFarmacéuticaFitnessMedio Ambiente/EcologíaSanidad

3 Comunicados de prensa

Ver todos los comunicados de prensa
Press Release cover image
24/07/2026
Salud
Fitness
Medicina - Varios
Medio Ambiente/Ecología
Agricultura
Laminar Pharma Announces "Last Patient, Last Visit" in LAM561 Phase 2b/3 Trial for Newly Diagnosed Glioblastoma Patients
Fuente
Laminar Pharmaceuticals, S.A.
Editor
PR News Wire
1.00
0
05/03/2025
Farmacéutica
Sanidad
Biología
Laminar Pharma Announces first open-label Progression-Free Survival data for LAM561 in combination with standard of Care in First-Line Therapy for Newly Diagnosed Glioblastoma MGMT-methylated patients
Fuente
Laminar Pharmaceuticals, S.A.
Editor
PR News Wire
1.00
0
Press Release cover image
11/06/2024
Farmacéutica
Sanidad
Last patient in: Laminar Pharmaceuticals S.A. completes recruitment for CLINGLIO, the phase 2b/3 Clinical Trial of idroxioleic acid (LAM561) in combination with RT and TMZ for adults with newly diagnosed glioblastoma
Fuente
Laminar Pharmaceuticals, S.A.
Editor
PR News Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0